The association of angina pectoris with heart disease mortality among men and women by diabetes status: The rancho Bernardo study

Journal of Women's Health

Volumn 19, Issue 8, 2010, Pages 1433-1439

  Carpiuc, Kimbach T ^a,b   Wingard, Deborah L ^a   Kritz Silverstein, Donna ^a   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; AGED, 80 AND OVER; ANGINA PECTORIS; BLOOD GLUCOSE; CALIFORNIA; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS;

EID: 77955257792     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2009.1649     Document Type: Article

References (53)

1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics-2007 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;115:e69-171.
2. Wingard DL, Barrett-Connor E. Heart disease and diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, eds. Diabetes in America, 2nd ed. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 1995:429-448.
3. Kanaya AM, Grady D, Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: A meta-analysis. Arch Intern Med 2002;162:1737-1745.
4. Hemingway H, Langenberg C, Damant J, Frost C, Pyorala K, Barrett-Connor E. Prevalence of angina in women versus men: A systematic review and meta-analysis of international variations across 31 countries. Circulation 2008;117:1526-1536.
5. Kannel WB, Feinleib M. Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol 1972;29:154-163.
6. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population. Am Heart J 1986;111:383-390.
7. Murabito JM, Evans JC, Larson MG, Levy D. Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation 1993;88:2548-2555.
8. Weinblatt E, Shapiro S, Frank CW. Prognosis of women with newly diagnosed coronary heart disease-A comparison with course of disease among men. Am J Public Health 1973;63:577-593.
9. Orencia A, Bailey K, Yawn BP, Kottke TE. Effect of gender on long-term outcome of angina pectoris and myocardial infarction=sudden unexpected death. JAMA 1993;269:2392-2397.
10. Elveback LR, Connolly DC. Coronary heart disease in residents of Rochester, Minnesota. V. Prognosis of patients with coronary heart disease based on initial manifestation. Mayo Clin Proc 1985;60:305-311.
11. Hochman JS, McCabe CH, Stone PH, et al. Outcome and profile of women and men presenting with acute coronary syndromes: A report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1997;30:141-148.
12. Hueb W, Gersh BJ, Costa F, et al. Impact of diabetes on fiveyear outcomes of patients with multivessel coronary artery disease. Ann Thorac Surg 2007;83:93-99.
13. Gerber Y, Weston SA, Killian JM, Jacobsen SJ, Roger VL. Sex and classic risk factors after myocardial infarction: A community study. Am Heart J 2006;152:461-468.
14. Peterson PN, Spertus JA, Magid DJ, et al. The impact of diabetes on one-year health status outcomes following acute coronary syndromes. BMC Cardiovasc Disord 2006;6:41.
15. Mozaffarian D, Bryson CL, Spertus JA, McDonell MB, Fihn SD. Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease. Am Heart J 2003;146:1015-1022.
16. Hemingway H, McCallum A, Shipley M, Manderbacka K, Martikainen P, Keskimaki I. Incidence and prognostic implications of stable angina pectoris among women and men. JAMA 2006;295:1404-1411.
17. The Lipid Research Clinics Program Epidemiology Committee. Plasma lipid distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study. Circulation 1979;60:427-439.
18. Criqui MH, Frankville DD, Barrett-Connor E, Klauber MR, Holdbrook MJ, Turner JD. Change and correlates of change in high and low density lipoprotein cholesterol after six years: A prospective study. Am J Epidemiol 1983;118: 52-59.
19. Criqui MH, Barrett-Connor E, Austin M. Differences between respondents and nonrespondents in a populationbased cardiovascular disease study. Am J Epidemiol 1978; 108:367-372.
20. The Hypertension Detection and Follow-Up Program. Hypertension Detection and Follow-Up Program Cooperative Group. Prev Med 1976;5:207-215.
21. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 1962;27:645-658.
22. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Helath Organization, 1999.
23. Fuller JH, McCartney P, Jarrett RJ, et al. Hyperglycaemia and coronary heart disease: The Whitehall study. J Chronic Dis 1979;32:721-728.
24. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart disease-Mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. N Engl J Med 1996;334:884-890.
25. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339:861-867.
26. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999;81:380-386.
27. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000;355:675-687. (Pubitemid 30107623)
28. Capewell S, Beaglehole R, Seddon M, McMurray J. Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 2000;102:1511-1516.
29. Cooper R, Cutler J, Svigne-Nickens P, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: Findings of the National Conference on Cardiovascular Disease Prevention. Circulation 2000;102:3137-3147.
30. McGovern PG, Jacobs DR Jr., Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: The Minnesota Heart Survey. Circulation 2001;104:19-24.
31. Ergin A, Muntner P, Sherwin R, He J. Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States. Am J Med 2004;117:219-227.
32. Zaher C, Goldberg GA, Kadlubek P. Estimating angina prevalence in a managed care population. Am J Manag Care 2004;10:S339-S346.
33. Reynolds MW, Frame D, Scheye R, et al. A systematic review of the economic burden of chronic angina. Am J Manag Care 2004;10:S347-S357.
34. Javitz HS, Ward MM, Watson JB, Jaana M. Cost of illness of chronic angina. Am J Manag Care 2004;10:S358-S369.
35. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: Meta-analysis of 37 prospective cohort studies. BMJ 2006;332:73-78.
36. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG. Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study. J Am Coll Cardiol 1993;22:1788-1794.
37. Kanaya AM, Herrington D, Vittinghoff E, et al. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease. Ann Intern Med 2005;142:813-820.
38. Wingard DL, Barrett-Connor EL, Ferrara A. Is insulin really a heart disease risk factor? Diabetes Care 1995;18:1299-1304.
39. Fuller JH, Keen H, Jarrett RJ, et al. Haemostatic variables associated with diabetes and its complications. BMJ 1979; 2:964-966.
40. Goldschmid MG, Barrett-Connor E, Edelstein SL, Wingard DL, Cohn BA, Herman WH. Dyslipidemia and ischemic heart disease mortality among men and women with diabetes. Circulation 1994;89:991-997.
41. Kannel WB, Vokonas PS. Demographics of the prevalence, incidence, and management of coronary heart disease in the elderly and in women. Ann Epidemiol 1992;2:5-14.
42. Alexander KP, Shaw LJ, Shaw LK, Delong ER, Mark DB, Peterson ED. Value of exercise treadmill testing in women. J Am Coll Cardiol 1998;32:1657-1664.
43. Lehmann JB, Wehner PS, Lehmann CU, Savory LM. Gender bias in the evaluation of chest pain in the emergency department. Am J Cardiol 1996;77:641-644.
44. Scirica BM, Moliterno DJ, Every NR, et al. Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators. Am J Cardiol 1999;84:1145-1150.
45. Jaglal SB, Slaughter PM, Baigrie RS, Morgan CD, Naylor CD. Good judgement or sex bias in the referral of patients for the diagnosis of coronary artery disease? An exploratory study. Can Med Assoc J 1995;152:873-880.
46. Shaw LJ, Miller DD, Romeis JC, Kargl D, Younis LT, Chaitman BR. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994;120:559-566.
47. Goldberg R, Goff D, Cooper L, et al. Age and sex differences in presentation of symptoms among patients with acute coronary disease: The REACT Trial. Rapid Early Action for Coronary Treatment. Coronary Artery Dis 2000;11:399-407.
48. Roger VL, Jacobsen SJ, Pellikka PA, Miller TD, Bailey KR, Gersh BJ. Gender differences in use of stress testing and coronary heart disease mortality: A population-based study in Olmsted County, Minnesota. J Am Coll Cardiol 1998;32: 345-352.
49. Persell SD, Baker DW. Aspirin use among adults with diabetes: Recent trends and emerging sex disparities. Arch Intern Med 2004;164:2492-2499.
50. Cull CA, Neil HA, Holman RR. Changing aspirin use in patients with type 2 diabetes in the UKPDS. Diabetes Med 2004;21:1368-1371.
51. Tonstad S, Rosvold EO, Furu K, Skurtveit S. Undertreatment and overtreatment with statins: The Oslo Health Study 2000-2001. J Intern Med 2004;255:494-502. (Pubitemid 38446363)
52. Wexler DJ, Grant RW, Meigs JB, Nathan DM, Cagliero E. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005;28:514-520.
53. Gulati M, Cooper-DeHoff RM, McClure C, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease. Arch Intern Med 2009;169: 843-850.